De San - Diagnostisch Handboek

6.1

Hart- en vaatziekten


	- 6 Hart- en vaatziekten - 6.1 Vetstofwisseling en cardiovasculaire complicaties - 6.1.6 Literatuur

6.1.6 Literatuur

1. The metabolic basis of inherited disease, 6th edition. pp 1129-1309. Scriver AL, Beaudet WS, Sly D. (eds).New York: McGraw-Hill, 1989.
2. Thompson, GR. A handbook of hyperlipidaemia. London: Current Science Ltd., 1994
3. Grundy SM, Vega GL. Causes of high blood cholesterol. Circulation 1989; 81: 412-427.
4. Triglycerides: the role in diabetes and atherosclerosis. Atherosclerosis Reviews, Vol. 22. Gotto AM, Paoletti R (eds). New York: Raven Press, 1991.
5. Report on the National Cholesterol Education Program Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults. Arch Intern Med 1988; 148: 36-69.
6. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J 1994; 15: 1300-1331.
7. Erkelens DW. Cholesterolconsensus. Ned Tijdschr Geneeskd 1987; 131: 1564-1569.
8. Erkelens DW. Herziening Consensus Cholesterol. Ned Tijdschr Geneeskd 1991; 135: 2337-2340.
9. MAAS investigators. Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS). Lancet 1994; 344: 633-638.
10. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-1389.
11. West of Scotland Coronary Prevention Study Group. Baseline risk factors and their association with outcome in the West of Scotland Coronary Prevention Study. Am J Cardiol 1997; 79: 756-762.
12. Pedersen TR, Olsson AG, FÆrgeman O, Kjekshus J, Wedel H, Berg K, et al. Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S). Circulation 1998; 97:1453-1460.
13. Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyörälä K. Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on coronary prevention. Eur Heart J 1998;19:1434-1503.
14. Smilde TJ, van Wissen S, Wollersheim H, Trip MD, Kastelein JJP, Stalenhoef AFH. Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolemia: a randomised trial. Lancet 2001; 357: 256-259.

Verder in deze paragraaf:
- Geen gerelateerde onderwerpen beschikbaar

Print deze pagina